ONS Guidelines Article

Lymphedema: Clinical Summary of the ONS Guidelines™ for Cancer Treatment–Related Lymphedema

Chelsea Backler

Marcia Beck

Ellen Poage

lymphedema, evidence-based practice, exercise, prospective surveillance
CJON 2020, 24(5), 566-570. DOI: 10.1188/20.CJON.566-570

Secondary (acquired) lymphedema is a chronic condition lacking a known cure that most commonly results from cancer treatment, particularly for breast, gynecologic, prostate, and head and neck cancers; lymphoma; and melanoma, and affects an estimated 1 in 1,000 Americans. Lymphedema is characterized by an accumulation of protein-rich lymphatic fluid in the affected part of the body. It can potentially affect functioning, family roles and relationships, occupational roles, and productivity. The majority of strategies to prevent and manage lymphedema are nonpharmacologic, used alone or in combination with one another.

Members Only
Not a current ONS member or journal subscriber?

Purchase This Article

Receive a PDF to download and print.